5-HT4 Receptors in Lower Urinary Tract Tissues

[1]  P. Saxena,et al.  Serotonin receptors as cardiovascular targets , 1997 .

[2]  M. Tonini,et al.  Cisapride enhances detrusor contractility and improves micturition in a woman with lazy bladder. , 1997, Scandinavian journal of urology and nephrology.

[3]  G. Sant,et al.  Carbachol-induced bladder mast cell activation: augmentation by estradiol and implications for interstitial cystitis. , 1996, Urology.

[4]  M. Tonini,et al.  5-HT4 receptor agonists and bladder disorders. , 1996, Trends in pharmacological sciences.

[5]  M. Tonini,et al.  Neural 5‐HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists , 1996, British journal of pharmacology.

[6]  I. Martínez-Mir,et al.  [Pollakiuria and micturition syndrome related to fluoxetine]. , 1995, Medicina clínica (Ed. impresa).

[7]  E. Wong,et al.  Rs-100235: A high affinity 5-HT4 receptor antagonist , 1995 .

[8]  R. Eglen,et al.  Pharmacological characterization of two novel and potent 5‐HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo , 1995, British journal of pharmacology.

[9]  W. Frishman,et al.  Serotonin and Serotonin Antagonism in Cardiovascular and Non‐Cardiovascular Disease , 1995, Journal of clinical pharmacology.

[10]  M. Tonini,et al.  5‐Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea‐pig isolated detrusor muscle , 1995, British journal of pharmacology.

[11]  H. Kao,et al.  The 5‐HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. , 1995, The EMBO journal.

[12]  P. Pillans,et al.  Cisapride increases micturition frequency. , 1994, Journal of clinical gastroenterology.

[13]  A. Kaumann.  Do human atrial 5-HT4 receptors mediate arrhythmias? , 1994, Trends in pharmacological sciences.

[14]  T. Iwanaga,et al.  Topographical relation between serotonin-containing paraneurons and peptidergic neurons in the intestine and urethra. , 1994, Biological signals.

[15]  M. Tonini,et al.  Characterization of the 5‐HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle , 1994, British journal of pharmacology.

[16]  I. Boyd,et al.  Urinary disorders associated with cisapride , 1994 .

[17]  A. Ford,et al.  Evidence for an inhibitory 5‐HT4 receptor in urinary bladder of Rhesus and Cynomolgus monkeys , 1994, British journal of pharmacology.

[18]  J. Gale,et al.  GR113808: a novel, selective antagonist with high affinity at the 5‐HT4 receptor , 1994, British journal of pharmacology.

[19]  D. Clarke,et al.  The 5‐HT4 Receptor , 1993, Medicinal research reviews.

[20]  K. Anderson.  Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. , 1993, Pharmacological reviews.

[21]  E. Wong,et al.  RS 23597‐190: a potent and selective 5‐HT4 receptor antagonist , 1993, British journal of pharmacology.

[22]  Y. Pichon.  Comparative Molecular Neurobiology , 1992, EXS.

[23]  P. R. Manasse,et al.  Detrusor Mast Cells in Refractory Idiopathic Instability , 1992 .

[24]  M. Corsi,et al.  Pharmacological analysis of 5‐hydroxytryptamine effects on electrically stimulated human isolated urinary bladder , 1991, British journal of pharmacology.

[25]  T. Christmas,et al.  Characteristics of mast cells in normal bladder, bacterial cystitis and interstitial cystitis. , 1991, British journal of urology.

[26]  R. McCallum.  Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology. , 1991, The American journal of gastroenterology.

[27]  B. Haylen,et al.  Do women with idiopathic sensory urgency have early interstitial cystitis? , 1990, British journal of urology.

[28]  A. Cecio,et al.  Serotonin-, somatostatin- and chromogranin A-containing cells of the urethro-prostatic complex in the sheep. An immunocytochemical and immunofluorescent study. , 1990, Journal of anatomy.

[29]  M. Cohen.  Canine, but not rat bladder contracts to serotonin via activation of 5HT2 receptors. , 1990, The Journal of urology.

[30]  C. Prakash,et al.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. , 1988, Drugs.

[31]  T. Hedner,et al.  Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension. , 1988, American Journal of Hypertension.

[32]  G. Creasey,et al.  The action of Cisapride on the chronic constipation of paraplegia , 1988, Paraplegia.

[33]  C. Bowers,et al.  The efferent role of sensory axons in nerve-evoked contractions of bullfrog bladder , 1987, Neuroscience.

[34]  T. Iwanaga,et al.  Distribution of serotonin-immunoreactive paraneurons in the lower urinary tract of dogs. , 1987, The American journal of anatomy.

[35]  F. Debruyne,et al.  Influence of ketanserin (serotonin antagonist) on bladder and urethral function. , 1987, Urology.

[36]  P. Klarskov,et al.  Influence of serotonin on lower urinary tract smooth muscle in vitro. , 1986, British journal of urology.

[37]  N. Hollenberg.  Serotonin and the peripheral circulation. , 1986, Journal of Hypertension - Supplement.

[38]  J. Heiligers,et al.  Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M- and 5-HT2-type. , 1985, Journal of autonomic pharmacology.

[39]  J. Fondacaro,et al.  Action of Serotonin on the Gastrointestinal Tract , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[40]  G. Burnstock,et al.  A novel non-adrenergic, non-cholinergic nerve-mediated relaxation of the pig bladder neck: an examination of possible neurotransmitter candidates. , 1984, European journal of pharmacology.

[41]  B. B. Kumar.  Urinary incontinence associated with metoclopramide. , 1984, JAMA.

[42]  M. Dubois,et al.  Endocrine cells in the prostate gland, urothelium and brenner tumors , 1983, Virchows Archiv. B, Cell pathology including molecular pathology.

[43]  M. Costa,et al.  Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: Their projections in the guinea-pig small intestine , 1982, Neuroscience.

[44]  S. M. Callahan,et al.  ELECTRICAL AND MECHANICAL ACTIVITY OF THE ISOLATED LOWER URINARY TRACT OF THE GUINEA‐PIG , 1981, British journal of pharmacology.

[45]  A. Dahlström,et al.  The effect of transmural field stimulation on the serotonin content in rat duodenal enterochromaffin cells--in vitro. , 1979, Acta physiologica Scandinavica.

[46]  C. Torda.  HYPOTHALAMIC ADRENALINE SYNTHESIS AFTER STIMULATION OF THE MEDIAL FOREBRAIN BUNDLE , 1977, British journal of pharmacology.

[47]  M. Zar,et al.  Pharmacology of electrically evoked contractions of human bladder [proceedings]. , 1977, British journal of pharmacology.

[48]  G. Folkerts,et al.  Nitric oxide and bronchial hyperresponsiveness. , 1995, Archives internationales de pharmacodynamie et de therapie.

[49]  R. Hen,et al.  Structural and functional conservation of serotonin receptors throughout evolution. , 1993, EXS.

[50]  E. Giraldo,et al.  DAU 6285: a novel antagonist at the putative 5-HT4 receptor. , 1992, Life sciences.

[51]  G. Sant,et al.  Activation of bladder mast cells in interstitial cystitis. , 1992, International journal of tissue reactions.

[52]  J. Fozard,et al.  The 5-HT4 receptor: a place in the sun. , 1992, Trends in pharmacological sciences.

[53]  Nestler Je,et al.  Effect of metoclopramide on diabetic neurogenic bladder. , 1983 .

[54]  A. Kawaoi,et al.  IMMUNOHISTOCHEMICAL DEMONSTRATION OF SEROTONIN (5HT)-CONTAINING CELLS IN THE HUMAN AND RAT INTESTINES , 1982 .

[55]  M. S. Rao,et al.  Clinical import of serotonin activity in the bladder and urethra. , 1981, The Journal of urology.